Pharmaceutical & Medical Devices
Today’s pharmaceutical and medical device organizations operate amidst a highly competitive marketplace and increasing regulatory and government scrutiny. Drawing on unmatched experience, specialized knowledge and a collaborative, action-oriented approach, Huron has delivered customized financial and operational solutions that have provided significant value for more than 60 leading life sciences companies. 
Pharmaceutical & Medical Devices INSIGHTS
Perspective: The Final Rule: 6 Key Areas of Compliance Focus
The Centers for Medicare & Medicaid Services (CMS) issued the Covered Outpatient Drugs Final Rule in January 2016. For compliance officers, the Final Rule’s impact will be felt in a variety of areas — but there are specific aspects that should remain top of mind.» MORE

Update: CMS Manufacturer Release 97: Guidance on Additional Inflation-Adjusted Rebate for Generic Drugs
CMS published "Manufacturer Release #97" which provides manufacturers with much anticipated guidance on the CPI-U penalty for generic products and how the additional rebate should be calculated.» MORE

Resource: Clinical Research Management Briefing April 4, 2016
The Clinical Research Management Briefing (CRMB) is a weekly newsletter that Huron Consulting Group sends out to clients and interested parties.» MORE


Related Expertise
PROFESSIONALS
Alt text

David Gilman

Managing Director

Lester Cheng

Lester Cheng

Managing Director

Alt text

Marc Tomassi

Managing Director

Mark Linver

Mark Linver

Managing Director

Paul J. Silver

Paul J. Silver

Managing Director and Practice Leader

Resource

International Medical Device Compliance Code Compendium

First published as a bound reference guide in 2007, the International Medical Device Compliance Code Compendium provides a comprehensive listing of region- and country-level codes of conduct developed by self-regulatory bodies in the medical device sector as well as comparative analyses with the most recent guidance provided by AdvaMed.